Malignant Penile Neoplasm — Trials

Malignant Penile Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

94 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 43
Recruiting: 22
Ph III recruiting: 0
Growth YoY: —
Industry share: 14%
Top sponsor: National Cancer Institute (NCI)
Termination share: —
Trials / 1,000 deaths: 120.1 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (7)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07378670	DEfeating PEnile CAncer-2(DEPECA-2)	recruiting	N/A	80	University Hospital TuebingenOTHER	1	Sep 25, 2026	clinicaltrials
NCT05899361	A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest	recruiting	N/A	10	Dana-Farber Cancer InstituteOTHER	1	Oct 24, 2023	clinicaltrials